Topic

Stephen Schirra ’14 (CLAS) in Bahía de Caráquez, Manabí, Ecuador, in April 2016. At each stop, Schirra leaves the kids with soccer balls so they can keep the game going. (Photo courtesy of Stephen Schirra)

Te Gusta Fútbol?

Stephen Schirra ’14 (CLAS) has turned his passion for soccer and travel into a career, teaching underprivileged children across the globe how to play the sport.

Rampi Ramprasad, professor of materials science and engineering, received a grant from the Toyota Research Institute. The project will involve design of functional polymers using advanced quantum mechanical computations and machine learning. Photo taken on March 30, 2017. (Sean Flynn/UConn Photo)

UConn Joins Hunt for New Materials

UConn researcher Ramamurthy Ramprasad is working to identify new polymers as part of the Toyota Research Institute's new $35 million initiative using AI to accelerate materials science discovery.

Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses a new drug just approved by the FDA. (Stock Image)

Expert Discusses First and Only Drug Approved for Progressive Multiple Sclerosis

Dr. Matthew Tremblay, who specializes in the care of patients with multiple sclerosis at UConn Health, discusses a new drug just approved by the FDA.

More PSMA, more problems. Prostate cells with more prostate-specific membrane antigen (PSMA) have more cancer cells (purple), growing in a more disorganized way, than the open ducts in a prostate whose cells have little PSMA. (Caromile and Shapiro/UConn Health Image)

Mark of Malignancy Identified in Prostate Cancer

Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.

Pathobiology professor Paulo Verardi began working to develop a vaccine for the Zika virus at the height of last year's outbreak in his native country Brazil. (Elizabeth Caron/UConn Photo)

Responding to a Crisis: A Vaccine for Zika

Pathobiology professor Paulo Verardi began working to develop a vaccine for the Zika virus at the height of last year's outbreak in his native country Brazil.

UConn wordmark.

UConn Commended for Financial Reporting Practices

The Government Finance Officers Association has awarded UConn the Certificate of Achievement for Excellence in Financial Reporting for its report on the 2016 fiscal year.

Cycles & Cyclones – Riding on the Wheels of Opportunity

There’s a storm brewing and Albert Einstein, famed physicist, caught wind of it.

Japanese barberry (Berberis thunbergii) with new leaves, flower buds, and berries. (Getty Images)

Invasive Japanese Barberry to Gain Ground with Climate Change

One of New England’s invasive species, Japanese barberry, will remain and flourish in new areas under predicted temperature increases, while the other, garlic mustard, will head north, says a new study.

The young and the useless. Oligodendrocyte progenitor cells like these never mature properly in patients with primary progressive multiple sclerosis.

Sick Stem Cells Point to Better MS Drugs

UConn Health researchers think they know why a particularly aggressive form of multiple sclerosis has so far proved unresponsive to drug treatments. They hope this knowledge will help develop better treatments.

Students took part in a 24-hour competition this past weekend to come up with solutions to problems associated with allergies and allergic reactions. (Sean Flynn/UConn Photo)

Student Innovators Create Solutions to Allergies

Students took part in a 24-hour competition this past weekend to come up with solutions to problems associated with allergies and allergic reactions.